Last night, our CEO Jutta Reinhard-Rupp joined partners from 11 countries & the EU to advance pandemic preparedness - aligning global R&D, investment and science to accelerate antiviral treatments for high-risk viruses.
📢 Don’t miss our request for proposals (RFP): TB scientist for Bioneer Q-RFIA TB clinical evaluation
Application deadline: 19 November 2026
More information: https://t.co/8X4yjosJZo
#DiagnosisForAll#EndTB#clinicalevaluation
📢Explore our latest calls for partners:
Request for proposals (RFP): HQ statutory audit
Deadline: 22 October 2026
Expression of interest (EOI): manufacturers of continuous glucose monitoring (CGM) devices willing to test practical access models for LMICs
Deadline: 31 October 2026
EOI: in-vitro diagnostic (IVD) partner to apply to a Horizon Europe call for the translation of a host-response mRNA signature to a portable point-of-care molecular diagnostic platform and advancing the assay to market in LMICs
Deadline: 6 November 2026
More info: https://t.co/dmGv5VfECk
UNGA adopts the Political Declaration on pandemic preparedness. Thanks @ArmeniaUN & @RwandaUN for your leadership.
The #100DaysMission is now recognized in a UN political declaration. Diagnostics first, made & accessible locally and regionally.
@WHO@IPPSecretariat@CEPIvaccines
Heading to #WHS2026? Join FIND’s CEO Dr Jutta Reinhard-Rupp & the Global Diagnostics Coalition on Oct 13 for "Driving collective action to close the diagnostic gap."
Let’s mobilize support & investment for equitable access to testing.
#DiagnosisForAll #WorldHealthSummit #WHS2026 #GlobalHealth #Diagnostics
📢The FIND Board has officially announced the appointment of Dr Jutta Reinhard-Rupp as Chief Executive Officer of FIND, following her successful tenure as Interim CEO since May 2026.
Under her leadership, FIND continues to advance breakthrough diagnostic solutions that support its vital mission: ensuring equitable access to reliable diagnosis worldwide.
Read the announcement: https://t.co/nFFLgHw8Ft
#DiagnosisForAll
What can investments in global health make possible?
Through @EDCTP, EU investments advance new health tools, build scientific capacity & attract additional funding, with every €1 mobilizing more than €1 from other sources.
Read our paper: https://t.co/h9Bs2DCQrX
The 100 Days Mission seeks to deliver diagnostics, treatments & vaccines within 100 days of a pandemic threat.
Today at #DevexUNGA81, our key partners @IPPSecretariat@DNDi@CEPIvaccines@UNITAID@MedsPatentPool discussed practical ways to turn that goal into readiness.
#DiagnosisForAll
Chagas disease affects ~8 million people worldwide, yet reliable diagnostics remain out of reach for far too many.
Through CUIDA Chagas, FIND and its partners are tackling the supply chain, regulatory, and procurement barriers limiting access across Bolivia, Brazil, Colombia, and Paraguay.
Check out the latest project newsletter for key insights on Trypanosoma cruzi detection tools and recommendations to expand access across the region. 👇
https://t.co/RV0owybE1l
#DiagnosisForAll #ChagasDisease
➡️ FIND’s abstract: “From Months to Days: How Community Leadership Transformed Hepatitis C Care for People who inject drugs (PWIDs)” has been selected for the 12th International Viral Hepatitis Elimination Meeting (IVHEM) 2026 taking place from 3-4 September in Hiroshima, Japan.
Read more to learn how operational bottlenecks to hepatitis care can be reduced by embedding lived experience into programme design and empowering communities as equal partners.
Abstract available on page 37 of the official abstract book 📖 https://t.co/sqL2Ik34yu
Global commitments are shifting into concrete action to improve access to essential medicines, diagnostics and medical devices for noncommunicable diseases. Availability and affordability of medicines, diagnostics and devices must be supported by: ✅ evidence-based selection and use ✅ stronger regulatory systems ✅ effective demand forecasting and procurement ✅ cohesive pricing policies ✅ inclusion in health benefit packages ✅ financed as part of UHC.
Ending non-communicable diseases requires all hands on deck: governments, donors, the private sector, and global partners.
Together, we can #ActOnNCDs.
Discover how @HelmsleyTrust is supporting our work: https://t.co/DeaD2kakRL
⏰It's time to #LeadOnNCDs! 💪FIND has joined the Global Week for Action! Let's call on leaders to: ✅Implement NCD policies ✅Break down siloes in the response ✅Mobilise investments ✅Stay true to the promises ✅Involve people living w/ #NCDs https://t.co/AETtMfpR8S #DiagnosisForAll
How can we expand sustainable access to life-saving HPV DNA testing for more women?
With support from FIND, the Hai Phong Department of Health 🇻🇳 developed a co-payment model rooted in scientific evidence, policy frameworks, and local implementation capacity offering a clear roadmap for scalable cervical cancer screening. Learn more: https://t.co/6czdJEm3Qh
Last week, we were delighted to welcome students from Zhengzhou University in China. Their curiosity, enthusiasm and interest in our work made the visit truly special. Thank you for spending time with us, we hope the experience inspires the next generation of global health leaders.
#GlobalHealth #DiagnosisForAll
The Meghalaya Users Forum (MUF), in collaboration with Meghalaya AIDS Control Society (MACS), National Viral Hepatitis Control Programme (NVHCP), Meghalaya State Network of Positive People (MSNP) and Foundation for Innovative New Diagnostics (FIND), observed....
Community-led approaches work! This #WorldHepatitisDay2026, we celebrated the impact of the HEP CARE initiative in Meghalaya alongside NVHCP, MACS, MUF, & DREAM Mission.
Together, we’re breaking down barriers, stigma, & hepatitis.
#DiagnosisForAll#EndHepatitis